Patents by Inventor Karen Annette Duggan

Karen Annette Duggan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions for the treatment of hypertension and/or fibrosis
    Patent number: 11834417
    Abstract: The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of hypertension and/or fibrosis.
    Type: Grant
    Filed: May 10, 2021
    Date of Patent: December 5, 2023
    Assignee: VECTUS BIOSYSTEMS LIMITED
    Inventor: Karen Annette Duggan
  • Compositions for the treatment of pulmonary fibrosis
    Patent number: 11401245
    Abstract: The present invention relates to compounds and their use in the prophylactic and/or therapeutic treatment of pulmonary fibrosis and/or related conditions.
    Type: Grant
    Filed: January 6, 2021
    Date of Patent: August 2, 2022
    Assignee: VECTUS BIOSYSTEMS LIMITED
    Inventor: Karen Annette Duggan
  • Compositions for the Treatment of Hypertension and/or Fibrosis
    Publication number: 20210284612
    Abstract: The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of hypertension and/or fibrosis.
    Type: Application
    Filed: May 10, 2021
    Publication date: September 16, 2021
    Applicant: Vectus Biosystems Limited
    Inventor: Karen Annette DUGGAN
  • Compositions for the treatment of hypertension and/or fibrosis
    Patent number: 11053202
    Abstract: The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of hypertension and/or fibrosis.
    Type: Grant
    Filed: September 21, 2017
    Date of Patent: July 6, 2021
    Assignee: Vectus Biosystems Limited
    Inventor: Karen Annette Duggan
  • COMPOSITIONS FOR THE TREATMENT OF PULMONARY FIBROSIS
    Publication number: 20210130301
    Abstract: The present invention relates to compounds and their use in the prophylactic and/or therapeutic treatment of pulmonary fibrosis and/or related conditions.
    Type: Application
    Filed: January 6, 2021
    Publication date: May 6, 2021
    Applicant: Vectus Biosystems Limited
    Inventor: Karen Annette DUGGAN
  • Compositions for the treatment of pulmonary fibrosis
    Patent number: 10919863
    Abstract: The present invention relates to compounds and their use in the prophylactic and/or therapeutic treatment of pulmonary fibrosis and/or related conditions.
    Type: Grant
    Filed: July 28, 2017
    Date of Patent: February 16, 2021
    Assignee: Vectus Biosystems Limited
    Inventor: Karen Annette Duggan
  • Compositions for the Treatment of Hypertension and/or Fibrosis
    Publication number: 20200255384
    Abstract: The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of hypertension and/or fibrosis.
    Type: Application
    Filed: September 21, 2017
    Publication date: August 13, 2020
    Inventor: Karen Annette DUGGAN
  • COMPOSITIONS FOR THE TREATMENT OF PULMONARY FIBROSIS
    Publication number: 20190270712
    Abstract: The present invention relates to compounds and their use in the prophylactic and/or therapeutic treatment of pulmonary fibrosis and/or related conditions.
    Type: Application
    Filed: July 28, 2017
    Publication date: September 5, 2019
    Applicant: Vectus Biosystems Limited
    Inventor: Karen Annette DUGGAN
  • Compositions for the Treatment of Hypertension and/or Fibrosis
    Publication number: 20190225588
    Abstract: The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of hypertension and/or fibrosis.
    Type: Application
    Filed: September 21, 2017
    Publication date: July 25, 2019
    Inventor: Karen Annette DUGGAN
  • Compositions for the treatment of kidney and/or liver disease
    Patent number: 10183908
    Abstract: The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of kidney and/or liver disease.
    Type: Grant
    Filed: March 18, 2016
    Date of Patent: January 22, 2019
    Assignee: VECTUS BIOSYSTEMS LIMITED
    Inventor: Karen Annette Duggan
  • Compositions for the treatment of fibrosis and fibrosis-related conditions
    Patent number: 10035775
    Abstract: The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of fibrosis and fibrosis-related conditions.
    Type: Grant
    Filed: March 18, 2016
    Date of Patent: July 31, 2018
    Assignee: VECTUS BIOSYSTEMS LIMITED
    Inventor: Karen Annette Duggan
  • COMPOSITIONS FOR THE TREATMENT OF FIBROSIS AND FIBROSIS-RELATED CONDITIONS
    Publication number: 20180072682
    Abstract: The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of fibrosis and fibrosis-related conditions.
    Type: Application
    Filed: March 18, 2016
    Publication date: March 15, 2018
    Applicant: VECTUS BIOSYSTEMS LIMITED
    Inventor: KAREN ANNETTE DUGGAN
  • COMPOSITIONS FOR THE TREATMENT OF KIDNEY AND/OR LIVER DISEASE
    Publication number: 20180037539
    Abstract: The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of kidney and/or liver disease.
    Type: Application
    Filed: March 18, 2016
    Publication date: February 8, 2018
    Applicant: VECTUS BIOSYSTEMS LIMITED
    Inventor: Karen Annette DUGGAN
  • VIP fragments and methods of use
    Patent number: 9732136
    Abstract: The invention relates to composition comprising a pharmaceutically effective amount of one or more functional vasoactive intestinal peptide (VIP) fragments, and the use of those compositions in the treatment of fibrosis, hypertension and other disorders.
    Type: Grant
    Filed: April 19, 2016
    Date of Patent: August 15, 2017
    Assignee: VECTUS BIOSYSTEMS LIMITED
    Inventor: Karen Annette Duggan
  • Compositions for the treatment of hypertension and/or fibrosis
    Patent number: 9630935
    Abstract: The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of hypertension and/or fibrosis.
    Type: Grant
    Filed: September 17, 2014
    Date of Patent: April 25, 2017
    Assignee: VECTUS BIOSYSTEMS LIMITED
    Inventor: Karen Annette Duggan
  • Compositions for the treatment of hypertension and/or fibrosis
    Patent number: 9458093
    Abstract: The present invention relates to a novel terphenyl compound and its use in the prophylactic and/or therapeutic treatment of hypertension and/or fibrosis.
    Type: Grant
    Filed: September 17, 2014
    Date of Patent: October 4, 2016
    Assignee: Vectus Biosystems Limited
    Inventor: Karen Annette Duggan
  • COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION AND/OR FIBROSIS
    Publication number: 20160280671
    Abstract: The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of hypertension and/or fibrosis.
    Type: Application
    Filed: September 17, 2014
    Publication date: September 29, 2016
    Inventor: Karen Annette Duggan
  • COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION AND/OR FIBROSIS
    Publication number: 20160221933
    Abstract: The present invention relates to a novel terphenyl compound and its use in the prophylactic and/or therapeutic treatment of hypertension and/or fibrosis.
    Type: Application
    Filed: September 17, 2014
    Publication date: August 4, 2016
    Inventor: Karen Annette Duggan
  • VIP FRAGMENTS AND METHODS OF USE
    Publication number: 20160222078
    Abstract: The invention relates to composition comprising a pharmaceutically effective amount of one or more functional vasoactive intestinal peptide (VIP) fragments, and the use of those compositions in the treatment of fibrosis, hypertension and other disorders.
    Type: Application
    Filed: April 19, 2016
    Publication date: August 4, 2016
    Inventor: Karen Annette Duggan
  • VIP fragments and methods of use
    Patent number: 9340583
    Abstract: The invention relates to composition comprising a pharmaceutically effective amount of one or more functional vasoactive intestinal peptide (VIP) fragments, and the use of those compositions in the treatment of fibrosis, hypertension and other disorder.
    Type: Grant
    Filed: November 17, 2014
    Date of Patent: May 17, 2016
    Assignee: Vectus Biosystems Limited
    Inventor: Karen Annette Duggan